Algeria vs Oman: Share of the population living with HIV receiving antiretroviral therapy
Algeria
68.3%
in 2024
Oman
67.7%
in 2024
Algeria rank
85th
Oman rank
87th
Share of the population living with HIV receiving antiretroviral therapy over time
- Algeria
- Oman
How they compare
Algeria currently reports 68.3% against 67.7% in Oman, a difference of 0.6%.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Oman ahead.
Algeria ranks 85th and Oman ranks 87th of 149 countries.
Across the 4 decades both report, Algeria averaged higher in 3 and Oman in 1.
Head to head by decade
| Decade | Algeria | Oman | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.3% | 0.0% | 1.3% | Algeria |
| 2000s | 10.3% | 18.5% | 8.2% | Oman |
| 2010s | 46.6% | 38.5% | 8.1% | Algeria |
| 2020s | 70.9% | 61.5% | 9.4% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Algeria or Oman?
- Algeria, at 68.3% against 67.7% in Oman as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Algeria and Oman?
- 0.6%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Oman?
- 35 years are reported by both, from 1990 to 2024.
- How do Algeria and Oman rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Algeria ranks 85th and Oman ranks 87th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.